As of 2026-05-03, the Relative Valuation of Axsome Therapeutics Inc (AXSM) is (78.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 206.53 USD, the upside of Axsome Therapeutics Inc based on Relative Valuation is -138.1%.
The range of the Relative Valuation is (78.71) - (68.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 29.0x | 26.0x |
| Forward P/E multiples | 17.3x - 19.1x | 18.0x |
| Fair Price | (78.71) - (68.33) | (78.78) |
| Upside | -138.1% - -133.1% | -138.1% |
| Date | P/E |
| 2026-05-01 | -57.67 |
| 2026-04-30 | -58.01 |
| 2026-04-29 | -51.37 |
| 2026-04-28 | -51.66 |
| 2026-04-27 | -52.33 |
| 2026-04-24 | -51.93 |
| 2026-04-23 | -51.02 |
| 2026-04-22 | -52.06 |
| 2026-04-21 | -51.09 |
| 2026-04-20 | -52.69 |
| 2026-04-17 | -52.77 |
| 2026-04-16 | -51.43 |
| 2026-04-15 | -51.43 |
| 2026-04-14 | -51.43 |
| 2026-04-13 | -49.80 |
| 2026-04-10 | -49.74 |
| 2026-04-09 | -49.96 |
| 2026-04-08 | -48.36 |
| 2026-04-07 | -47.12 |
| 2026-04-06 | -47.40 |
| 2026-04-02 | -47.05 |
| 2026-04-01 | -47.97 |
| 2026-03-31 | -47.20 |
| 2026-03-30 | -44.82 |
| 2026-03-27 | -43.66 |
| 2026-03-26 | -45.87 |
| 2026-03-25 | -45.18 |
| 2026-03-24 | -44.33 |
| 2026-03-23 | -43.80 |
| 2026-03-20 | -43.82 |
| 2026-03-19 | -44.37 |
| 2026-03-18 | -44.08 |
| 2026-03-17 | -45.01 |
| 2026-03-16 | -44.18 |
| 2026-03-13 | -43.58 |
| 2026-03-12 | -43.04 |
| 2026-03-11 | -44.54 |
| 2026-03-10 | -46.45 |
| 2026-03-09 | -45.93 |
| 2026-03-06 | -45.33 |
| 2026-03-05 | -45.09 |
| 2026-03-04 | -45.82 |
| 2026-03-03 | -45.81 |
| 2026-03-02 | -46.46 |
| 2026-02-27 | -45.77 |
| 2026-02-26 | -45.57 |
| 2026-02-25 | -45.86 |
| 2026-02-24 | -47.46 |
| 2026-02-23 | -48.80 |
| 2026-02-20 | -51.30 |